Back

CRISPR/Cas9 gene editing for heart disease: ready for prime time? - Chat Moderator.

29 August 2021 (10:30 - 11:15)
Organised by:
Congress Presentation Part of: CRISPR/Cas9 gene editing for heart disease: ready for prime time? Pharmacology and Pharmacotherapy ESC Premium Access ESC Congress 2021 - The Digital Experience

4 More presentations in this session

Presentation thumbnail
Gene editing on its way to the clinics.
Professor E. McNally (Chicago, US)
Slides Video
Presentation thumbnail
Strategies to promote homology-directed repair in post-mitotic cardiomyocytes.
Associate Professor S. Higo (Osaka, JP)
Slides Video
Presentation thumbnail
Prime editing without double-strand breaks or donor DNA.
Presentation thumbnail
CRISPR/Cas9 gene editing for heart disease: ready for prime time? – discussion.

Access the full session

Session thumbnail
CRISPR/Cas9 gene editing for heart disease: ready for prime time?
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

29 August 2021 10:30 CET
You may be interested in
thumbnail
Congress Session
Challenges in hypertension management
thumbnail
Congress Presentation
Dynamics of indicators of central hemodynamics and arterial wall rigidity during the background of combination therapy with amlodipine/ valsartan in patients with arterial hypertension
thumbnail
Congress Session
Optimal management of chronic coronary syndromes: putting the evidence into practice

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources